Streamline Health Solns Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $4.33M Beat $4.31M Estimate
Portfolio Pulse from Benzinga Newsdesk
Streamline Health Solutions (NASDAQ: STRM) reported a Q1 EPS of $(0.05), missing the $(0.04) estimate, while sales of $4.33M beat the $4.31M estimate. Sales decreased by 18.79% compared to the same period last year.
June 11, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Streamline Health Solutions reported a Q1 EPS of $(0.05), missing the $(0.04) estimate, while sales of $4.33M beat the $4.31M estimate. Sales decreased by 18.79% compared to the same period last year.
The missed EPS estimate is likely to have a negative impact on the stock price in the short term, despite the slight beat in sales. The significant year-over-year decrease in sales further adds to the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100